Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Reports Promising Initial Mineral Resource Estimate at Iron Creek Cobalt Project in Idaho

Iron Creek estimates call for 45 million pounds (20,411 tonnes) of cobalt Drilling underway for expanded resource estimate that’s expected in 2019 Board strengthened with appointment of CEO of electric vehicle innovator Cobalt resource estimates in North America just got a boost, after First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) released the results […]

GreenBox POS, LLC (GRBX) Delivering Cashless Solutions to Meet Evolving Needs of Diverse Market Sectors

Average daily GreenBox transaction volume projected to reach $1 million by 4Q2018 Recently announced completion of parent company takeover, ensuring that all assets are now transferred onto GRBX’s books as planned Acquisition of Sky Mids Technologies includes Sky’s book of transactional business capable of processing greater than $1 billion annually Global point-of-sale terminals market expected […]

NUGL Inc. (NUGL) Cannabis Networking Software Building Steam with Customer-Responsive Outlook

NUGL pressing first mover status with wide array of search variables for cannabis consumers Recent “Stock Day” interview and sales VP addition highlight company’s increasing exposure to marketplace NUGL exceeds estimates for application downloads and sign-ups NUGL Inc. (OTC: NUGL), an internet-based search engine that gives cannabis users a responsive directory specialized to their need […]

Earth Science Tech, Inc. (ETST) Sees DEA Decision to Reschedule CBD Opening Doors for Development of Treatments for Multiple Illnesses

U.S. Drug Enforcement Agency’s (DEA) decision to remove certain CBD products from its Schedule 1 list of controlled substances will make CBD clinical studies easier to plan ETST’s pipeline includes CBD-based pharmaceutical formulas; company expects its pure hemp oil and new formulas to eventually be sold worldwide ETST will be a licensed distributor and plans […]

Youngevity International, Inc. (NASDAQ: YGYI) Targeting the CBD Market

Youngevity is a top omni-direct lifestyle business The company is leveraging growth opportunities related to cannabidiol oil Company added two new hemp-derived cannabidiol products, expanding HempFX line to five offerings Youngevity International, Inc. (NASDAQ: YGYI) is among the ‘Top 100 Global Direct Selling Companies’. Along with unique services, Youngevity offers products from the top selling […]

Cannabis Strategic Ventures, Inc. (NUGS) Boasts Robust, Ever-Growing Portfolio as it Cultivates the World’s Cannabis Brand Leaders

Vertically integrated company presents an international approach to the multibillion-dollar cannabis industry Cannabis Strategic is currently developing a CBD-based luxury skincare and haircare line with True Promise Beauty, slated for release during winter 2018 Company is focused on acquisition, incubation and development of startup and growth-stage cannabis companies Cannabis Strategic Ventures, Inc. (OTC: NUGS) is […]

BriaCell Therapeutics Corp.’s (OTCQB: BCTXF) (TSX.V: BCT) Lead Candidate Shows Promising Anti-Tumor Activity in Proof of Concept Study

Company achieves positive proof of concept in Phase IIa study of its lead product candidate, Bria-IMT, in advanced breast cancer patients Efficacy data comparable to that of other approved breast cancer therapies in a similar stage of development Combination study with immune checkpoint inhibitors in the works, enrollment already open BriaCell Therapeutics Corp. (OTCQB: BCTXF) […]

 

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease (‘CHD’) Detection

June 26, 2026

Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings (NASDAQ: CDIO) reports that approximately 50% of individuals with coronary heart disease do not present with traditional risk […]

Rotate your device 90° to view site.